Pharmacokinetic interactions between Japanese traditional medicine (kampo) and modern medicine (III). Effect of Sho-seiryu-to on the pharmacokinetics of azelastine hydrochloride in rats

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 5, 2004, Pages 670-673

  Makino, Toshiaki ^a   Inagaki, Takahiro ^a   Komatsu, Ken Ichi ^a   Kano, Yoshihiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Azelastine; Ephedrine; Herb drug interaction; Kampo; Sho seiryu to

Indexed keywords

AZELASTINE; EPHEDRINE; SHO SEIRYU TO; HERBACEOUS AGENT; PHTHALAZINE DERIVATIVE; SHO-SEIRYU-TO;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG INFORMATION; ENZYME ACTIVITY; FEMALE; HERB DRUG INTERACTION; MEAN RESIDENCE TIME; NONHUMAN; RAT; STOMACH ABSORPTION; TRADITIONAL MEDICINE; ANIMAL; CHEMISTRY; CHINESE MEDICINE; COMPARATIVE STUDY; SPRAGUE DAWLEY RAT;

ANIMALS; DRUGS, CHINESE HERBAL; FEMALE; MEDICINE, KAMPO; PHTHALAZINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 16644386248     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.670     Document Type: Article

References (22)

1. Part II: Makino T., Wakushima H., Okamoto T., Okukubo Y., Deguchi Y., Kano Y., Phytother. Res., 17, 1021-1024 (2003).
2. Astin J., J. Am. Med. Assoc., 279, 1548-1553 (1998).
3. Rister R., "Japanese Herbal Medicine: The Healing Art of Kampo," Avery Publishers Group, New York, 1999.
4. Cupp M. J., Am. Fam. Physician, 59, 1239-1245 (1999).
5. Kao S. T., Lin C. S., Hsieh C. C., Hsieh W. T., Lin J. G., Allergy, 56, 1164-1171 (2001).
6. Kao S. T., Wang S. D., Wang J. Y., Yu C. K., Lei H. Y., Allergy, 55, 1127-1133 (2000).
7. Yamanaka T., Shoji T., Murakami M., Igarashi T., Arzneimittelforschung, 31, 1203-1206 (1981).
8. Ohnishi N., Yonekawa Y., Nakasako S., Nagasawa K., Yokoyama T., Yoshioka M., Kuroda K., Biol. Pharm. Bull., 22, 527-531 (1999).
9. Kimura M., Hasegawa A., Nakamura H., Ohmori S., Ishii I., Kitada M., Jpn. J. Pharm. Health. Care Sci., 28, 360-365 (2002).
10. Japanese Pharmacopoeia Convention, "Japanese Pharmacopoeia," 14th ed., Ishiyaku Shuppan, Tokyo, 2001.
11. Ishigami M., Kawabata K., Takasaki W., Ikeda T., Komai T., Ito K., Sugiyama Y., Drug Metab. Dispos., 29, 1068-1072 (2001).
12. Yamaoka K., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).
13. Tabata K., Yamaoka K., Kaibara A., Suzuki S., Terakawa M., Hata T., Xenobio. Metab. Dispos., 14, 286-293 (1999).
14. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
15. Nakajima M., Ohyama K., Nakamura S., Shimada N., Yamazaki H., Yokoi T., Drug Metab. Dispos., 27, 792-797 (1999).
16. Jonderko K., Kucio C., Aliment Pharmacol. Ther., 5, 413-418 (1991).
17. Hull K. M., Zanzillari R., Maher T. J., Pharmacol. Biochem. Behav., 46, 411-414 (1993).
18. Noguchi M., Kubo M., Hayashi T., Ono M., Chem. Pharm. Bull., 26, 3652-3657 (1978).
19. Li B., Shan Dong J. Trad. Chin. Med., 2, 28-29 (1990).
20. Smolinske S. C., J. Am. Med. Women. Assoc., 54, 191-195 (1999).
21. Ameer B., Weintraub R., Clin. Pharmacokinet., 33, 103-121 (1997).
22. Ioannides C., Xenobiotica, 32, 451-478 (2002).